NANO-X IMAGING (NNOX) LTD announced that its deep-learning medical imaging analytics subsidiary, Nanox AI, has received EU MDR CE mark certification for HealthOST, an SaMD for bone health analysis, enabling its commercialization across Europe and ensuring compliance with the highest regulatory standards for medical software. HealthOST is Nanox.AI’s advanced Bone Solution, which analyzes routine CT scans to assess vertebral height loss and bone mineral density. Building on its FDA 510(k) clearance received in April 2022, HealthOST leverages AI to provide qualitative and quantitative analysis of the spine from CT scans to support clinicians in the evaluation and assessment of musculoskeletal disease of the spine, such as osteoporosis, which can remain undiagnosed until life-altering fractures occur.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NNOX:
- Nano-X Imaging Reports Q1 2025 Financial Results and Growth
- Nano-X Imaging Ltd. Earnings Call: Growth Amid Challenges
- Nano-X Imaging price target lowered to $7 from $9 at Alliance Global Partners
- Nanox Imaging Reports Q1 2025 Financial Results and FDA Clearance
- Nano-X Imaging reports Q1 EPS (21c) vs (21c) last year
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue